3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Ovarian Neoplasms
3
Uterine Neoplasms
1
Small Cell Lung Carcinoma
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Lung Neoplasms
1
Kenny-Caffey syndrome, Type 1
1
Endometrial Neoplasms
1
Interventions
Paclitaxel
6
Carboplatin
6
Radiotherapy
5
olaparib
4
Surveys and Questionnaires
4
Cisplatin
4
Surgical Procedures, Operative
3
Sentinel Lymph Node Biopsy
3
Metformin
3
pembrolizumab
2
lenvatinib
2
durvalumab
2
dostarlimab
2
anlotinib
2
Reverse Transcriptase Polymerase Chain Reaction
2
Progesterone
2
Magnetic Resonance Spectroscopy
2
Injections
2
High-Energy Shock Waves
2
Hematologic Tests
2
Genetic Testing
2
Docetaxel
2
Blood Specimen Collection
2
Base Sequence
2
Amplified Fragment Length Polymorphism Analysis
2
vistusertib
1
serabelisib
1
pazopanib
1
palbociclib
1
onapristone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Endometrial Neoplasms
×
Poly(ADP-ribose) Polymerase Inhibitors
×
Clear all
NCT03951415
2021-04-01
DOMEC
Leiden University Medical Center
Phase 2
Unknown
55 enrolled